The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
D003920:Diabetes Mellitus / Q000628:therapy*; D007004:Hypoglycemic Agents; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds; D014050:Toluene / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D013453:Sulfonylurea Compounds; C083195:4-tolylsulfonylurea; D000077145:Sulfanilamide; D014050:Toluene; D014508:Urea
DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/related compounds